CICLOSPORIN EYEDROPS (Verkazia®)

Clinical Indication

Treatment of severe vernal keratoconjunctivitis (VKC) in children from 4 years of age and adolescents

Date of classification

April 2021

Review date

April 2021

Amber SIMPLE

Drugs suitable to be initiated and prescribed in primary care only after specialist assessment and recommendation. A shared care agreement is not required.